How optimal allocation of limited testing capacity changes epidemic dynamics
View ORCID ProfileJustin M. Calabrese, View ORCID ProfileJeffery Demers
doi: https://doi.org/10.1101/2020.12.21.20248431
Justin M. Calabrese
1Center for Advanced Systems Understanding (CASUS), Goerlitz, Germany
Jeffery Demers
2Dept. of Biology, University of Maryland, College Park, MD, USA
Data Availability
Only parameter estimates from the literature were used, with values summarized in Table 1, and all sources listed in the literature cited.
Posted September 08, 2021.
How optimal allocation of limited testing capacity changes epidemic dynamics
Justin M. Calabrese, Jeffery Demers
medRxiv 2020.12.21.20248431; doi: https://doi.org/10.1101/2020.12.21.20248431
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2767)
- Dermatology (236)
- Emergency Medicine (415)
- Epidemiology (12420)
- Forensic Medicine (10)
- Gastroenterology (785)
- Genetic and Genomic Medicine (4285)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2765)
- Health Policy (1025)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4061)
- Nursing (218)
- Nutrition (602)
- Oncology (2143)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6667)
- Radiology and Imaging (1455)
- Respiratory Medicine (887)
- Rheumatology (425)
- Sports Medicine (353)
- Surgery (466)
- Toxicology (57)
- Transplantation (194)
- Urology (171)